Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Lon HK"'
Autor:
Soltantabar P; Oncology Research and Development, Pfizer Inc, San Diego, California, USA., Sharma S; Oncology Research and Development, Pfizer Inc, San Diego, California, USA.; Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA., Wang D; Oncology Research and Development, Pfizer Inc, San Diego, California, USA., Lon HK; Oncology Research and Development, Pfizer Inc, San Diego, California, USA., Czibere A; Oncology Research and Development, Pfizer Inc, San Diego, California, USA., Hickmann A; Oncology Research and Development, Pfizer Inc, San Diego, California, USA., Elmeliegy M; Oncology Research and Development, Pfizer Inc, San Diego, California, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1258-1268. Date of Electronic Publication: 2024 Mar 08.
Autor:
Hanafin PO; GSK, Collegeville, PA, USA., Murthy A; University of Texas at Austin, Austin, TX, USA., Marathe D; Gilead Sciences, Morris Plains, NJ, USA., Diep JK; Ionis Pharmaceuticals, Inc, Carlsbad, CA, USA., Krishnatry AS; GSK, Collegeville, PA, USA., Lon HK; Pfizer Inc, San Diego, CA, USA., Shah DK; University at Buffalo, State University of New York, Buffalo, NY, USA., Ait-Oudhia S; Merck & Co., Inc, Kenilworth, New Jersey, USA. sb.manuscript.submission@gmail.com., Rao GG; Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. gaurirao@live.unc.edu.
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2023 Aug; Vol. 50 (4), pp. 243-250.
Autor:
Soltantabar P; Global Product Development, Pfizer Inc, San Diego, CA, USA., Lon HK; Global Product Development, Pfizer Inc, San Diego, CA, USA., Parivar K; Global Product Development, Pfizer Inc, San Diego, CA, USA., Wang DD; Global Product Development, Pfizer Inc, San Diego, CA, USA., Elmeliegy M; Global Product Development, Pfizer Inc, San Diego, CA, USA. Electronic address: Mohamed.Elmeliegy@pfizer.com.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2023 Feb; Vol. 182, pp. 103913. Date of Electronic Publication: 2023 Jan 19.
Autor:
Solh, M, Bahlis, NJ, Raje, NS, Costello, CL, Dholaria, B, Levy, MY, Tomasson, MH, Dube, H, Damore, MA, Lon, HK, Basu, C, Skoura, A, Chan, EM, Trudel, S, Jakubowiak, A, Chu, MP, Gasparetto, C, Dalovisio, A, Sebag, M, Lesokhin, AM
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2021 43 Supplement 1:S195-S196
Autor:
Höglinger GU; German Center for Neurodegenerative Diseases, Munich, Germany; Department of Neurology, Technische Universität München, Munich, Germany; Department of Neurology, Hannover Medical School, Hannover, Germany. Electronic address: hoeglinger.guenter@mh-hannover.de., Litvan I; Parkinson and Other Movement Disorders Center, University of California San Diego, La Jolla, CA, USA., Mendonca N; Neuroscience, AbbVie Inc, North Chicago, IL, USA., Wang D; Data and Statistical Sciences, AbbVie Inc, North Chicago, IL, USA., Zheng H; Data and Statistical Sciences, AbbVie Inc, North Chicago, IL, USA., Rendenbach-Mueller B; Neuroscience, AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany., Lon HK; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Jin Z; Data and Statistical Sciences, AbbVie Inc, North Chicago, IL, USA., Fisseha N; Neuroscience, AbbVie Inc, North Chicago, IL, USA., Budur K; Neuroscience, AbbVie Inc, North Chicago, IL, USA., Gold M; Neuroscience, AbbVie Inc, North Chicago, IL, USA., Ryman D; Neuroscience, AbbVie Inc, North Chicago, IL, USA., Florian H; Neuroscience, AbbVie Inc, North Chicago, IL, USA.
Publikováno v:
The Lancet. Neurology [Lancet Neurol] 2021 Mar; Vol. 20 (3), pp. 182-192.
Autor:
Lon HK; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Cheng L; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Nudurupati S; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Loebbert R; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Duan R; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Kalabic J; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Pang Y; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA. Electronic address: yinuo.pang@abbvie.com.
Publikováno v:
Clinical therapeutics [Clin Ther] 2021 Mar; Vol. 43 (3), pp. 629-636. Date of Electronic Publication: 2021 Feb 03.
Autor:
Brunasso, Alexandra Maria Giovanna1 (AUTHOR), Salvi, Ilaria2,3 (AUTHOR), Sorbara, Stefania4 (AUTHOR), Muracchioli, Andrea5 (AUTHOR), De Col, Elena6 (AUTHOR), Baldari, Manuela7 (AUTHOR), Parodi, Aurora2,3 (AUTHOR), Cozzani, Emanuele2,3 (AUTHOR), Burlando, Martina2,3 (AUTHOR) martina.burlando@unige.it
Publikováno v:
Skin Research & Technology. Aug2024, Vol. 30 Issue 8, p1-4. 4p.
Autor:
Lon HK; AbbVie Inc., North Chicago, IL, USA., Mendonca N; AbbVie Inc., North Chicago, IL, USA., Goss S; AbbVie Inc., North Chicago, IL, USA., Othman AA; AbbVie Inc., North Chicago, IL, USA., Locke C; AbbVie Inc., North Chicago, IL, USA., Jin Z; AbbVie Inc., North Chicago, IL, USA., Rendenbach-Mueller B; AbbVie Inc., North Chicago, IL, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 Apr; Vol. 8 (3), pp. 290-303. Date of Electronic Publication: 2018 Jul 27.
Autor:
Baudry, Michel1,2 (AUTHOR) mbaudry@westernu.edu, Wang, Yubin1 (AUTHOR), Bi, Xiaoning1 (AUTHOR), Luo, Yun Lyna1 (AUTHOR), Wang, Zhijun3 (AUTHOR), Kamal, Zeechan4 (AUTHOR), Shirokov, Alexander4 (AUTHOR), Sullivan, Ed4 (AUTHOR), Lagasca, Dennis4 (AUTHOR), Khalil, Hany4 (AUTHOR), Lee, Gary4 (AUTHOR), Fosnaugh, Kathy2 (AUTHOR), Bey, Philippe2 (AUTHOR), Mehdi, Shujaath2 (AUTHOR), Coulter, Greg2 (AUTHOR)
Publikováno v:
Pharmacology Research & Perspectives. Apr2024, Vol. 12 Issue 2, p1-15. 15p.
Oligonucleotide-Based Drug Development: Considerations for Clinical Pharmacology and Immunogenicity.
Autor:
Wang J; 1 Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, MD, USA., Lon HK; 1 Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, MD, USA.; 2 Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA., Lee SL; 3 Office of Hematology and Oncology Products, Office of New Drugs, US Food and Drug Administration, Silver Spring, MD, USA., Burckart GJ; 1 Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, MD, USA., Pisetsky DS; 4 Medical Research Service, Durham VA Medical Center and Duke University Medical Center, Durham, NC, USA.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2015 Nov; Vol. 49 (6), pp. 861-868.